Johns Hopkins ABX Guide
Ceftazidime
Ceftazidime is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia caused by P. aeruginosa and other Pseudomonas spp., H. influenzae, Klebsiella spp., Enterobacter spp., P. mirabilis, E. coli, Serratia spp., and Citrobacter spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Skin and skin-structure infections caused by P. aeruginosa, Klebsiella spp., E. coli,Proteus spp. including P. mirabilisand indole-positive Proteus, Enterobacter spp., and Serratia spp.
- Complicated and uncomplicated urinary tract infections caused by P. aeruginosa,Enterobacter spp., Proteus spp., including P. mirabilis and indole-positive Proteus, Klebsiella spp. and E. coli
- Septicemia caused by P. aeruginosa, Klebsiella spp., H. influenzae, E. coli, and Serratia spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Bone and joint infections caused by P. aeruginosa, Klebsiella spp., and Enterobacter spp.
- Gynecologic infections (endometritis, pelvic cellulitis, and other GYN infections) caused by E. coli
- Intra-abdominal Infections, including peritonitis caused by E. coli, Klebsiella spp., and polymicrobial infections caused by aerobic and anaerobic organisms (in combination with metronidazole)
- Central nervous system infections including meningitis, caused by H. influenzae , N. meningitidis, and P. aeruginosa
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections
- Diabetic foot infection (in combination with clindamycin)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia caused by P. aeruginosa and other Pseudomonas spp., H. influenzae, Klebsiella spp., Enterobacter spp., P. mirabilis, E. coli, Serratia spp., and Citrobacter spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Skin and skin-structure infections caused by P. aeruginosa, Klebsiella spp., E. coli,Proteus spp. including P. mirabilisand indole-positive Proteus, Enterobacter spp., and Serratia spp.
- Complicated and uncomplicated urinary tract infections caused by P. aeruginosa,Enterobacter spp., Proteus spp., including P. mirabilis and indole-positive Proteus, Klebsiella spp. and E. coli
- Septicemia caused by P. aeruginosa, Klebsiella spp., H. influenzae, E. coli, and Serratia spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Bone and joint infections caused by P. aeruginosa, Klebsiella spp., and Enterobacter spp.
- Gynecologic infections (endometritis, pelvic cellulitis, and other GYN infections) caused by E. coli
- Intra-abdominal Infections, including peritonitis caused by E. coli, Klebsiella spp., and polymicrobial infections caused by aerobic and anaerobic organisms (in combination with metronidazole)
- Central nervous system infections including meningitis, caused by H. influenzae , N. meningitidis, and P. aeruginosa
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections
- Diabetic foot infection (in combination with clindamycin)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 6, 2017
Citation
Dzintars, Kathryn, and Paul A Pham. "Ceftazidime." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime.
Dzintars K, Pham PA. Ceftazidime. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime. Accessed October 2, 2022.
Dzintars, K., & Pham, P. A. (2017). Ceftazidime. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime
Dzintars K, Pham PA. Ceftazidime [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2022 October 02]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftazidime
ID - 540101
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/12/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
